Potential biomarkers: Identifying powerful tumor specific T cells in adoptive cellular therapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential biomarkers: Identifying powerful tumor specific T cells in adoptive cellular therapy
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-11-14
DOI
10.3389/fimmu.2022.1003626
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pinpointing the tumor-specific T cells via TCR clusters
- (2022) Mikhail M Goncharov et al. eLife
- Tumor-Specific CD4+ T Cells Restrain Established Metastatic Melanoma by Developing Into Cytotoxic CD4– T Cells
- (2022) Qiao Liu et al. Frontiers in Immunology
- Circulating Exhausted PD-1+CD39+ Helper CD4 T Cells Are Tumor-Antigen-Specific and Predict Response to PD-1/PD-L1 Axis Blockade
- (2022) Carlos Martinez-Gomez et al. Cancers
- The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1+ tumour-infiltrating lymphocytes
- (2021) Diego Salas-Benito et al. BRITISH JOURNAL OF CANCER
- T cells expanded from PD-1+ peripheral blood lymphocytes share more clones with paired tumor-infiltrating lymphocytes
- (2021) Tiepeng Li et al. CANCER RESEARCH
- The CD39 positive hepatitis B virus surface protein (HBVs)-targeted CAR-T and personalized tumor-reactive CD8+ T cells exhibit potent anti-hepatocellular carcinoma (HCC) activity
- (2021) Fan Zou et al. MOLECULAR THERAPY
- T cells expanded from renal cell carcinoma display tumor-specific CD137 expression but lack significant IFN-γ, TNF-α or IL-2 production
- (2021) Saskia D. van Asten et al. OncoImmunology
- Single-cell analyses identify circulating anti-tumor CD8 T cells and markers for their enrichment
- (2021) Kristen E. Pauken et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells
- (2021) Rebekka Duhen et al. Nature Communications
- CD39+PD-1+CD8+ T cells mediate metastatic dormancy in breast cancer
- (2021) Paulino Tallón de Lara et al. Nature Communications
- The Factors Affecting Expansion of Reactive Tumor Infiltrating Lymphocytes (TIL) From Bladder Cancer and Potential Therapeutic Applications
- (2021) Ahmet Murat Aydin et al. Frontiers in Immunology
- Single-cell profiles and prognostic impact of tumor-infiltrating lymphocytes co-expressing CD39, CD103, and PD-1 in ovarian cancer
- (2021) Céline M. Laumont et al. CLINICAL CANCER RESEARCH
- Intra-tumoral CD39+CD8+ T cells predict response to PD-1/PD-L1 blockade in patients with NSCLC
- (2021) Joe Yeong et al. Journal of Thoracic Oncology
- CD8+CD39+ T Cells Mediate Anti-Tumor Cytotoxicity in Bladder Cancer
- (2021) Wenjie Zhu et al. OncoTargets and Therapy
- Robust Antitumor Immunity in a Patient with Metastatic Colorectal Cancer Treated with Cytotoxic Regimens
- (2021) Venkatesh Rajamanickam et al. Cancer Immunology Research
- Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade
- (2021) Romain Banchereau et al. Journal for ImmunoTherapy of Cancer
- Systematic analysis of CD39, CD103, CD137, and PD‐1 as biomarkers for naturally occurring tumor antigen‐specific TILs
- (2021) Monika A. Eiva et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- CD39 Regulation and Functions in T Cells
- (2021) Eleonora Timperi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B
- (2021) Yanan Gao et al. JOURNAL OF HEPATOLOGY
- Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
- (2021) Justina X. Caushi et al. NATURE
- Intratumoral CXCR5+CD8+T associates with favorable clinical outcomes and immunogenic contexture in gastric cancer
- (2021) Jieti Wang et al. Nature Communications
- Single-cell profiling defines the prognostic benefit of CD39high tissue resident memory CD8+ T cells in luminal-like breast cancer
- (2021) Agnese Losurdo et al. Communications Biology
- Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens
- (2021) Arianna Draghi et al. Frontiers in Immunology
- Functional tumor specific CD8 + T cells in spleen express a high level of PD-1
- (2020) Zili Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Enhanced Phenotype Definition for Precision Isolation of Precursor Exhausted Tumor-Infiltrating CD8 T Cells
- (2020) Amaia Martinez-Usatorre et al. Frontiers in Immunology
- Characterization of CD103+ CD8+ tissue-resident T cells in esophageal squamous cell carcinoma: may be tumor reactive and resurrected by anti-PD-1 blockade
- (2020) Lu Han et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Relationship between T cell receptor clonotype and PD‐1 expression of tumor‐infiltrating lymphocytes in colorectal cancer
- (2020) Kenta Sukegawa et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Transcriptional Activity and Stability of CD39+CD103+CD8+ T Cells in Human High-Grade Endometrial Cancer
- (2020) Hagma H. Workel et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Genetically driven CD39 expression shapes human tumor‐infiltrating CD8 + T‐cell functions
- (2020) Daniela Gallerano et al. INTERNATIONAL JOURNAL OF CANCER
- CD39 identifies the CD4+ tumor-specific T cell population in human cancer
- (2020) Kim E Kortekaas et al. Cancer Immunology Research
- Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up
- (2020) Joost H van den Berg et al. Journal for ImmunoTherapy of Cancer
- Detecting Tumor Antigen-Specific T Cells via Interaction-Dependent Fucosyl-Biotinylation
- (2020) Zilei Liu et al. CELL
- Retrospective Analysis of Adoptive TIL Therapy plus Anti-PD1 Therapy in Patients with Chemotherapy-Resistant Metastatic Osteosarcoma
- (2020) Xiang Zhou et al. Journal of Immunology Research
- High-affinity neoantigens correlate with better prognosis and trigger potent antihepatocellular carcinoma (HCC) activity by activating CD39+CD8+ T cells
- (2020) Ting Liu et al. GUT
- Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer
- (2020) Sri Krishna et al. SCIENCE
- Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy
- (2019) Imran Siddiqui et al. IMMUNITY
- Tissue-Resident T Cells and Other Resident Leukocytes
- (2019) David Masopust et al. Annual Review of Immunology
- Adoptive Immunotherapy with Antigen-Specific T Cells Expressing a Native TCR
- (2019) Wingchi Leung et al. Cancer Immunology Research
- High-dimensional cytometric analysis of colorectal cancer reveals novel mediators of antitumour immunity
- (2019) Natasja L de Vries et al. GUT
- 4‐1BB Delineates Distinct Activation Status of Exhausted Tumor‐Infiltrating CD8 + T cells in Hepatocellular Carcinoma
- (2019) Hyung‐Don Kim et al. HEPATOLOGY
- Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytes
- (2019) Alena Gros et al. JOURNAL OF CLINICAL INVESTIGATION
- CD103+ T and Dendritic Cells Indicate a Favorable Prognosis in Oral Cancer
- (2019) Y. Xiao et al. JOURNAL OF DENTAL RESEARCH
- MHC-II neoantigens shape tumour immunity and response to immunotherapy
- (2019) Elise Alspach et al. NATURE
- VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium
- (2019) Dmitry V Bagaev et al. NUCLEIC ACIDS RESEARCH
- Self-maintaining CD103+ cancer-specific T cells are highly energetic with rapid cytotoxic and effector responses
- (2019) Megat Abd Hamid et al. Cancer Immunology Research
- An intra-tumoral niche maintains and differentiates stem-like CD8 T cells
- (2019) Caroline S. Jansen et al. NATURE
- Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4
- (2019) Jitske van den Bulk et al. Genome Medicine
- CD103 + CD8 + T lymphocytes in non-small cell lung cancer are phenotypically and functionally primed to respond to PD-1 blockade
- (2018) Peiliang Wang et al. CELLULAR IMMUNOLOGY
- Induction of Neoantigen-specific Cytotoxic T Cells and Construction of T-cell Receptor-engineered T cells for Ovarian Cancer
- (2018) Tatsuo Matsuda et al. CLINICAL CANCER RESEARCH
- CD103+Tumor-Resident CD8+T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment
- (2018) Jarem Edwards et al. CLINICAL CANCER RESEARCH
- Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma
- (2018) Chun Jye Lim et al. GUT
- Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
- (2018) Peter Savas et al. NATURE MEDICINE
- Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
- (2018) Thomas Duhen et al. Nature Communications
- High-dimensional single cell analysis identifies stem-like cytotoxic CD8+T cells infiltrating human tumors
- (2018) Jolanda Brummelman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
- (2018) Yannick Simoni et al. NATURE
- Resident memory T cells, critical components in tumor immunology
- (2018) Fathia Mami-Chouaib et al. Journal for ImmunoTherapy of Cancer
- Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers
- (2018) Wouter Scheper et al. NATURE MEDICINE
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- VDJdb: a curated database of T-cell receptor sequences with known antigen specificity
- (2017) Mikhail Shugay et al. NUCLEIC ACIDS RESEARCH
- Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent
- (2017) Alice O. Kamphorst et al. SCIENCE
- Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation
- (2017) Sivan Seliktar-Ofir et al. Frontiers in Immunology
- CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer
- (2017) Fenne L. Komdeur et al. OncoImmunology
- CD103 and Intratumoral Immune Response in Breast Cancer
- (2016) Z.-Q. Wang et al. CLINICAL CANCER RESEARCH
- Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression
- (2016) Maria Parkhurst et al. CLINICAL CANCER RESEARCH
- CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma
- (2016) Hagma H. Workel et al. EUROPEAN JOURNAL OF CANCER
- Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
- (2016) Alena Gros et al. NATURE MEDICINE
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- CD8+CD103+Tumor–Infiltrating Lymphocytes Are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer Patients
- (2015) Fayçal Djenidi et al. JOURNAL OF IMMUNOLOGY
- CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder
- (2015) Bo Wang et al. JOURNAL OF UROLOGY
- PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
- (2014) Alena Gros et al. JOURNAL OF CLINICAL INVESTIGATION
- CD137 Accurately Identifies and Enriches for Naturally Occurring Tumor-Reactive T Cells in Tumor
- (2013) Q. Ye et al. CLINICAL CANCER RESEARCH
- The developmental pathway for CD103+CD8+ tissue-resident memory T cells of skin
- (2013) Laura K Mackay et al. NATURE IMMUNOLOGY
- The Molecular Signature of Tissue Resident Memory CD8 T Cells Isolated from the Brain
- (2012) L. M. Wakim et al. JOURNAL OF IMMUNOLOGY
- PD1 makes waves in anticancer immunotherapy
- (2012) Alexandra Flemming NATURE REVIEWS DRUG DISCOVERY
- Selection of CD8+PD-1+ Lymphocytes in Fresh Human Melanomas Enriches for Tumor-reactive T Cells
- (2010) Takashi Inozume et al. JOURNAL OF IMMUNOTHERAPY
- Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
- (2009) M. Ahmadzadeh et al. BLOOD
- Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus
- (2009) Thomas Gebhardt et al. NATURE IMMUNOLOGY
- CD137-guided isolation and expansion of antigen-specific CD8 cells for potential use in adoptive immunotherapy
- (2008) Kazue Watanabe et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now